Daily Roundup

SPZ.ASX IMB.ASX TLX.ASX EOS.ASX IPX.ASX

Smart Parking Expands US Footprint with American Parking Deal

Smart Parking Limited has snapped up American Parking for USD $12 million, bolstering its presence across the United States. The acquisition brings SPZ's total US sites under management to over 200 locations, with American Parking contributing 54 sites spread across Oklahoma, Texas, and Arkansas. The deal is being funded through a mix of existing cash reserves, debt facilities, and SPZ shares.

American Parking generated USD $8.0 million in revenues and USD $1.4 million in EBITDA during 2025, and the transaction is expected to be accretive to earnings per share right out of the gate—even before any synergies kick in. For a company still early in its growth trajectory, this move signals continued momentum in the US parking market.

Intelligent Monitoring Group Makes Massive UK Play with ADT Acquisition

In a much larger move, Intelligent Monitoring Group is acquiring ADT's UK residential security business for GBP £180 million, a transformational deal that's set to reshape the company's earnings profile. The acquisition will add a whopping $12.5 million per month in recurring revenue from over 160,000 direct customers and is expected to increase IMG's pro forma annualised EBITDA by approximately 300% to A$130 million.

The numbers are compelling. IMG expects the deal to be materially earnings accretive, lifting pro forma EPS to 9.0 cents per share at current exchange rates—a roughly 40% accretion to earnings. The transaction, anticipated to complete in the first half of 2027, will be funded through a new debt facility and vendor equity placement, with no additional external equity capital required beyond the consideration shares. This is a significant growth platform for IMG, combining ADT's established brand with IMG's advanced video monitoring services.

Telix Clears FDA Hurdle for Prostate Cancer Trial

Telix Pharmaceuticals has secured FDA alignment to advance the ProstACT Global Phase 3 trial for its therapeutic candidate TLX591-Tx in metastatic castration-resistant prostate cancer. The FDA has confirmed the safety data from Part 1 and signed off on the clinical protocol and statistical framework for Part 2, which will involve three standard-of-care combination cohorts.

Part 2 is already recruiting patients across multiple jurisdictions including Australia, New Zealand, Canada, Türkiye, the United Kingdom, China, Singapore, and South Korea, with plans to enroll approximately 490 patients globally. This regulatory green light removes a key milestone risk and opens the door for US expansion of the trial.

EOS Lands A$38m in New Defence Orders

Electro Optic Systems has secured new sales orders worth approximately A$38 million, demonstrating solid demand for its defence and security solutions. The company landed a US$16 million (~A$23 million) order for its Naval R400 Remote Weapon System from a new Middle East customer, with deliveries expected over the next seven years.

Meanwhile, EOS's MARSS division—its command and control business—has locked in an £8 million (~A$15 million) counter-drone defence contract from an existing Middle East customer for a command and training centre. The bulk of this work is expected to be delivered during 2026 and 2027.

IperionX Unlocks High-Grade Critical Minerals in Tennessee

IperionX has completed its acquisition of the Camden critical mineral assets, strategically positioned next to its Titan Project in Tennessee. The deal delivers ultra-high-grade surface stockpiles enriched in titanium, zircon, and rare earth minerals—offering a 5x to 10x uplift in grades compared to Titan's average.

The real advantage here is that historical silica sand operations at Camden have already pre-processed these critical minerals into surface stockpiles, potentially slashing capital intensity and mining costs. The site also features pre-stripped Lower McNairy mineralization, giving rapid access to high-grade mineral seams and established infrastructure that could de-risk development timelines. IperionX is now accelerating drilling and metallurgical test work, with a formal mineral resource estimate expected by the end of 2026.